Finance

Lists
Q2 2027 earnings • 7:30 AM today
See results
FREDUN:NSE
Fredun Pharmaceuticals Ltd
₹1,520.00
+1.28%
(+19.20) 1D
Nov 16, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for FREDUN...
Open
₹1,515.90
High
₹1,537.00
Low
₹1,455.10
Mkt. cap
25.69B
Avg. vol.
141.07K
Volume
64.19K
P/E ratio
44.06
52-wk high
₹1,665.00
52-wk low
₹1,195.20
EPS
₹34.49
No. of employees
736
Open
₹1,515.90
High
₹1,537.00
Low
₹1,455.10
Mkt. cap
25.69B
Avg. vol.
141.07K
Volume
64.19K
P/E ratio
44.06
52-wk high
₹1,665.00
52-wk low
₹1,195.20
EPS
₹34.49
No. of employees
736
News stories
From web sources and news partners
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Just released
Today, 7:30 AM
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
2.66B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.60B
2.13B
2.28B
2.66B
Cost of goods sold
1.15B
1.60B
1.77B
1.98B
Cost of revenue
1.15B
1.60B
1.77B
1.98B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
81.46M
484.22M
71.21M
91.10M
Operating expense
210.93M
270.90M
216.29M
312.26M
Total operating expenses
1.36B
1.87B
1.99B
2.29B
Operating income
235.55M
252.32M
286.78M
366.46M
Other non operating income
9.97M
-49.65M
4.92M
17.82M
EBT including unusual items
140.02M
112.48M
205.52M
296.51M
EBT excluding unusual items
140.02M
112.48M
205.52M
296.51M
Income tax expense
35.24M
53.02M
74.20M
110.77M
Effective tax rate
25.17%
47.14%
36.10%
37.36%
Other operating expenses
111.63M
-244.82M
109.37M
181.88M
Net income
104.78M
59.45M
131.32M
185.74M
Net profit margin
6.55%
2.80%
5.77%
6.99%
Earnings per share
-
-
-
-
Interest and investment income
-
6.60M
-
-
Interest expense
-105.50M
-126.75M
-86.18M
-87.76M
Net interest expenses
-105.50M
-120.15M
-86.18M
-87.76M
Depreciation and amortization charges
17.84M
31.50M
35.71M
39.28M
EBITDA
247.83M
272.79M
307.24M
403.93M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps